Quantessence Capital LLC Portfolio Holdings

Quantessence Capital LLC

  • $400 Billion
  • Q1 2025

Quantessence Capital LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $400 Billion distributed in 332 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Intra Cellular Therapies, Inc. with a value of $30.3B, Select Sector Spdr Tr Communic with a value of $12.3B, Exxon Mobil Corp with a value of $11.3B, Beacon Roofing Supply Inc with a value of $10.8B, and Pfizer Inc with a value of $10.6B.

Examining the 13F form we can see an increase of $156B in the current position value, from $244B to 400B.

Quantessence Capital LLC is based out at New York, NY

Below you can find more details about Quantessence Capital LLC portfolio as well as his latest detailed transactions.

Portfolio value $400 Billion
Healthcare: $94.6 Billion
Financial Services: $51.5 Billion
Technology: $46.3 Billion
Industrials: $41 Billion
Consumer Defensive: $30.2 Billion
Energy: $27.6 Billion
Consumer Cyclical: $27 Billion
ETFs: $19.5 Billion
Other: $35.6 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$171M
$116 Million 0.03% of portfolio
36,421
Q1 2025 New
Contextlogic Inc
-
$139 Million 0.03% of portfolio
-
Q1 2025 New
$151M
$122 Million 0.03% of portfolio
40,000
Q1 2025 New
$7.48B
$126 Million 0.03% of portfolio
12,513
Q1 2025 New
Flotek Inds Inc Del
-
$120 Million 0.03% of portfolio
-
Q1 2025 New
$149M
$100 Million 0.03% of portfolio
34,533
Q1 2025 New
$74.4M
$115 Million 0.03% of portfolio
21,208
Q1 2025 New
$109M
$130 Million 0.03% of portfolio
118,349
Q1 2025 New
$22M
$87.8 Million 0.02% of portfolio
18,255
Q1 2025 New
Lionsgate Studios Corp
-
$93.5 Million 0.02% of portfolio
-
Q1 2025 New
$94M
$79 Million 0.02% of portfolio
51,664
Q1 2025 New
$129M
$76.3 Million 0.02% of portfolio
81,804
Q1 2025 New
$173M
$76.5 Million 0.02% of portfolio
37,523
Q1 2025 New
$2.76B
$97.3 Million 0.02% of portfolio
16,138
Q1 2025 New
$1.2B
$90.5 Million 0.02% of portfolio
77,362
Q1 2025 New
$90.4M
$85.5 Million 0.02% of portfolio
58,149
Q1 2025 New
$99.3M
$74.1 Million 0.02% of portfolio
20,124
Q1 2025 New
Bgc Group Inc
-
$91.7 Million 0.02% of portfolio
-
Q1 2025 Reduced 41.43%
$973M
$71.5 Million 0.02% of portfolio
13,008
Q1 2025 New
$43.3M
$56 Million 0.01% of portfolio
16,523
Q1 2025 New
$178M
$25.9 Million 0.01% of portfolio
11,973
Q1 2025 New
$385M
$34.7 Million 0.01% of portfolio
13,300
Q1 2025 New
$351M
$47.2 Million 0.01% of portfolio
17,612
Q1 2025 New
$240M
$50.4 Million 0.01% of portfolio
29,292
Q1 2025 New
$183M
$47.7 Million 0.01% of portfolio
10,480
Q1 2025 New
$66.6M
$54.6 Million 0.01% of portfolio
19,030
Q1 2025 New
$35.6M
$43.4 Million 0.01% of portfolio
10,188
Q1 2025 New
$131M
$41.8 Million 0.01% of portfolio
16,469
Q1 2025 New
Inhibikase Therapeutics Inc
-
$28.5 Million 0.01% of portfolio
-
Q1 2025 New
$159M
$50.1 Million 0.01% of portfolio
12,515
Q1 2025 New
$355M
$33.1 Million 0.01% of portfolio
12,650
Q1 2025 New

Summary

  • Portfolio
  • No. of Stocks 332
  • Current Value $400 Billion
  • Prior Value $244 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 266 stocks
  • Additional Purchases 41 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 24 stocks
Track This Portfolio

Track Quantessence Capital LLC Portfolio

Follow Quantessence Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantessence Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantessence Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email